tiprankstipranks
Fulgent Genetics (FLGT)
:FLGT
US Market

Fulgent Genetics (FLGT) Income Statement

Compare
1,626 Followers

Fulgent Genetics Income Statement

Last quarter (Q4 2024), Fulgent Genetics's total revenue was $76.21M, an increase of 8.10% from the same quarter last year. In Q4, Fulgent Genetics's net income was $-5.89M. See Fulgent Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 283.47M$ 289.21M$ 618.97M$ 992.58M$ 421.71M
Gross Profit
$ 107.22M$ 104.46M$ 366.90M$ 777.05M$ 331.90M
Operating Expenses
$ 181.13M$ 299.40M$ 185.40M$ 101.10M$ 41.75M
Depreciation and Amortization
$ 0.00$ 26.14M$ 36.91M$ 12.16M$ 3.37M
EBITDA
$ -73.92M$ -46.55M$ 221.59M$ 675.95M$ 290.16M
Operating Income
$ -73.92M$ -72.69M$ 178.53M$ 675.95M$ 290.16M
Other Income/Expenses
$ 21.96M$ -101.39M$ 5.50M$ 1.35M$ 1.53M
Pretax Income
$ -51.96M$ -174.09M$ 184.03M$ 677.30M$ 291.68M
Net Income
$ -42.71M$ -167.82M$ 143.40M$ 507.36M$ 214.31M
Per Share Metrics
Basic EPS
$ -1.41$ -5.63$ 4.76$ 17.13$ 9.64
Diluted EPS
$ -1.41$ -5.63$ 4.63$ 16.26$ 9.09
Weighted Average Shares Outstanding
30.23M 29.78M 30.10M 29.41M 22.69M
Weighted Average Shares Outstanding (Diluted)
30.23M 29.78M 30.96M 30.98M 24.06M
Currency in USD

Fulgent Genetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis